pubmed-article:1776859 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C0026900 | lld:lifeskim |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C0086661 | lld:lifeskim |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C0014939 | lld:lifeskim |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C1458155 | lld:lifeskim |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C0085983 | lld:lifeskim |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C0072473 | lld:lifeskim |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C1514559 | lld:lifeskim |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C0014930 | lld:lifeskim |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:1776859 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:1776859 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:1776859 | pubmed:dateCreated | 1992-2-28 | lld:pubmed |
pubmed-article:1776859 | pubmed:abstractText | In breast tumor cell lines, c-myc amplification is frequently associated with estrogen unresponsiveness. We, however, succeeded in characterizing an estrogen-responsive cell line VHB1 derived from a duct cell carcinoma, which exhibits c-myc amplification and overexpression. We therefore studied the effects of estrogen and antiestrogen on c-myc expression in this particular cell line. We also investigated these effects on the expression of c-mil and c-myb oncogenes, also expressed but not amplified in VHB1 cells. Short-(1 h) and long-(72 h) term stimulations were performed. Our experiments showed that estradiol (E2 10(-8) M) was still able to stimulate c-myc expression equally either after short or long-term treatment. In the same way, the antiestrogen 4-hydroxytamoxifen equally decreased c-myc expression but the reversal effect of E2 after long-term antiestrogen treatment was more pronounced than after short-term treatment. The effects of E2 and 4-OH Tam on the expression of the not-amplified c-mil and c-myb oncogenes were stronger than those observed on c-myc expression; however, the E2 reversal effect was identical either after short or long-term antiestrogen treatment. Our results may enlighten some aspects of the complex action of some of the early- and late-growth regulated genes in breast cancer. | lld:pubmed |
pubmed-article:1776859 | pubmed:language | eng | lld:pubmed |
pubmed-article:1776859 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1776859 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1776859 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1776859 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1776859 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1776859 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1776859 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1776859 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1776859 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1776859 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1776859 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1776859 | pubmed:issn | 0250-7005 | lld:pubmed |
pubmed-article:1776859 | pubmed:author | pubmed-author:KerckaertJ... | lld:pubmed |
pubmed-article:1776859 | pubmed:author | pubmed-author:Collyn-d'Hoog... | lld:pubmed |
pubmed-article:1776859 | pubmed:author | pubmed-author:LefebvreJJ | lld:pubmed |
pubmed-article:1776859 | pubmed:author | pubmed-author:VandewalleBB | lld:pubmed |
pubmed-article:1776859 | pubmed:author | pubmed-author:LantoineDD | lld:pubmed |
pubmed-article:1776859 | pubmed:author | pubmed-author:RevillionFF | lld:pubmed |
pubmed-article:1776859 | pubmed:author | pubmed-author:HorneiSS | lld:pubmed |
pubmed-article:1776859 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1776859 | pubmed:volume | 11 | lld:pubmed |
pubmed-article:1776859 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1776859 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1776859 | pubmed:pagination | 2175-9 | lld:pubmed |
pubmed-article:1776859 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:meshHeading | pubmed-meshheading:1776859-... | lld:pubmed |
pubmed-article:1776859 | pubmed:articleTitle | C-myc overexpression, c-mil, c-myb expression in a breast tumor cell line. Effects of estrogen and antiestrogen. | lld:pubmed |
pubmed-article:1776859 | pubmed:affiliation | U 124 INSERM, Lille, France. | lld:pubmed |
pubmed-article:1776859 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1776859 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1776859 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1776859 | lld:pubmed |